Schedule for Paper Presentation in the SNMINDIACON 2011

**9^th^ December, 2011 (Friday)**

**Convener: Dr Syed Mushtaq Ahmed, Srinagar**

0912SIP1 Hall B (17.00 -- 17.10 hrs.)

Rathore V S, Tiwari A K, Sehgal N *et al*. Design of DTPA-(bis amide) as AChE inhibitors for quantifying Nerve gases activity.

0912S1P2 Hall B (17.10 -- 17.20 hrs.)

Mitra A, Kulkarni S, Rajeh C *et al* Effect of ethanol in BET Assay performed by kinetic chromogenic method for \[^18^F\] Radiopharmaceuticals other than \[^18^F\]FDG.

0912S1P3 Hall B (17.20 -- 17.30 hrs.)

Shimpi H H, Nabar S J, Sonwane G A *et al*, 177Lu-DOTA-TATE synthesis: In house experience at RMC

0912S1P4 Hall B (17.30 -- 17.40 hrs.)

Sellam K, Bal C S, Gupta D *et al*, Evaluation of recurrent brain tumors in low grade primary gliomas with \[^18^F\] -- FDOPA PET- CT, \[^18^F\]- FDG PET --CT, ^99m^Tc -- GHA SPECT- CT and MRI.

0912S1P5 Hall B (17.40 -- 17.50 hrs.)

Ambade R N, Khan M S A, Shinde S N *et al*, Optimization of dry distillation method for production of 131I at pilot scale.

0912S1P6 Hall B (17.50 -- 18.00 hrs.)

Hegde R, Vijaya Raj K K, Mukherjee R *et al*, Synthesis and radiolabeling of Rifampicin Chelate Conjugate; a possible SPECT Imaging for Infection.

0912S2P7 Hall B (18.00 -- 18.10 hrs.)

Behera A, Banerjee I, De K *et al*, Radiosynthesis and biological evaluation of HYNIC- Tyr3Octreotide.

0912S2P8 Hall B (18.10 -- 18.20 hrs.)

Sethi S K, Raunak, Sandhya R *et al*, Synthesis and biological evaluation of D2- receptor based ligands labeled with SPECT radionuclide for neuroendocrine tumor.

0912S2P9 Hall B (18.20 -- 18.30 hrs.)

Blessy P, Anil P, Umer K *et al*, Experience with 68Ga DOTATOC synthesis module and imaging: Technologist perspective.

0912S2P10 Hall B (18.30 -- 18.40 hrs.)

Jha A K, Zade A, Rangarajan V *et al*, A Software Program and Database System for GFR Estimation by Plasma Sampling method.

0912S2P11 Hall B (18.40 -- 18.50 hrs.)

Santhanaraj B, Poovendiran K Analysis of teamviewer software for PET-SPECT images by Receiver Operating Characteristic Curves.

0912S2P12 Hall B (18.50 -- 19.00 hrs.)

Jatale P, Asopa R, Basu S *et al*, Analysis of quantitative parameters and its Comparison, between physical and pharmacological stress, obtained on myocardial perfusion SPECT imaging.

0912S2P99 Hall B (19.00 -- 19.10 hrs.)

Vishlavath S, Jaimini A, Tripati M *et al*, Application of \[^18^F\] FDG PET/CT imaging to monitor treatment response and detecting disease recurrence in tuberculosis.

0912S2P100 Hall B (19.10 -- 19.20 hrs.)

Vasumathi, Rajesh K, Pandit N *et al*, Analysis of various types of 99Mo- ^99m^Tc generator systems by considering the Eluent volume, Yield and Cost effectiveness

**10^th^ December, 2011 (Saturday)**

**Convener: Dr. Col JK Bhagat, Jaipur**

1012S3P13 Hall A (08.00 -- 08.10 hrs.)

Sahoo M K, Naswa N, Dhull V S *et al*, Role of \[^18^F\] FDG PET- CT in restaging of patients with recurrent malignant melanoma.

1012S3P14 Hall A (08.10 -- 08.20 hrs.)

Jora C, Jacob M J, Chauhan M S *et al*, Dual Time Point Imaging with \[^18^F\] FDG and its comparison with MRI in primary brain tumors -- A pilot Study.

1012S3P15 Hall A (08.20 -- 08.30 hrs.)

Jain A, Shelly S, Indirani M *et al*, Assessing the diagnostic utility of \[^18^F\] FDG PET in Carcinoma of Unknown primary.

1012S3P16 Hall A (08.30 -- 08.40 hrs.)

Imam S K, El- Maghraby T *et al*, Assessment of cancer therapy: \[^18^F\] FDG vs FLT.

1012S3P17 Hall A (08.40 -- 08.50 hrs.)

Lakshmipathy KM, Deepak K A, Sureshkumar A C *et al*. Justification of routine WB \[^18^F\] FDG with dual phase contrast CT in Head and Neck cancers.

1012S3P18 Hall A (08.50 -- 09.00 hrs.)

Sahoo S, Kand P, Basu S *et al*, Added advantage of ^99m^Tc- MDP Bone SPECT and \[^18^F\] Fluoride PET study, compared to planar bone scan in difficult cases.

**10^th^ December, 2011 (Saturday)**

**Convener: Dr. N Sivaprasad, Mumbai**

1012S4P19 Hall B (08.00 -- 08.10 hrs.)

Gupta C, Pankaj P, Verma R *et al*, Role of Gallium -- 68 labeled DOTANOC PET- CT in evaluation of Neuroendocrine tumour.

1012S4P20 Hall B (08.10 -- 0820 hrs.)

Jain S C, Reddy A R, Impact of new ICRP recommendations on Radiation Dose from Radiopharmaceuticals to ICRP and Indian Adult.

1012S4P21 Hall B (08.20 -- 08.30 hrs.)

Singh H, Patel C, Sharma G *et al*, Estimation of Left Ventricular function and dyssynchrony using equilibrium radionuclide angiography in patients with Right Ventricular Outflow Tract pacing -- A six month follow- up study.

**Competition for Shakuntala Krishnamurthy Nuclear Hepatology Award**

1012S4C22 Hall B (08.30 -- 08.40 hrs.)

Mukherjee R U, Ghosh S, Mangale V *et al*, Liver tumour imaging using a ^99m^Tc- labeled RGD peptide in a mouse model

1012S4C23 Hall B (08.40 -- 08.50 hrs.)

Borde C R, Sundaram P S , Hepatobiliary Scintigraphy; Lighting the Right (hepatobiliary) track

1012S4C24 Hall B (08.50 -- 09.00 hrs.)

Das K J, Sharma P, Singh H *et al*, Hybrid SPECT- CT with ^99m^Tc- Mebrofenin for detection and localization of Postoperative and Posttraumatic Bile leak.

1012S4C93 Hall B (09.00 -- 09.10 hrs)

Arun S, Sampath S, Manohar K *et al*, Role of ^99m^Tc mebrofenin SPECT- CT in hepatobiliary scintigraphy in suspected cases of biliary leak.

1012S4C96 Hall B (09.10 -- 09.20 hrs.)

Santhosh S, Sasikumar A, Kuruva M *et al*, Cholescintigraphy in biliary dyskinesia: a reappraisal.

**11^th^ December, 2011 (Sunday)**

**Convener: Dr. Lt. Col. G. Dhananjayan, ERNAKULAM**

1112S5P25 Hall A (08.00 -- 08.10 hrs.)

Kaul A, Babbar A K, Attri A *et al*, In vitro bacterial binding assay of Scintibact (^99m^Tc -- CAX) in isolates of *Staphylococcus aureus*.

1112S5P26 Hall A (08.10 -- 08.20 hrs.)

Kumar A, Aijaz T, Kumaresan K, *et al*, Effect of Gastro- jejunostomy technique on gastric emptying in patients undergoing Whipple\'s surgery -- Scintigraphic evaluation with liquids and solid meal.

1112S5P27 Hall A (08.20 -- 08.30 hrs.)

Murari S B, Tejonath G, Ranadheer *et al*, Dacryoscintigraphy: A valuable tool in the management of epiphora.

Competition for Dr. N. Ramadas Award for Best Paper in Nuclear Thyroidology

1112S5C28 Hall A (08.30 -- 08.40 hrs.)

Parmar M, Dutta P, Sood A *et al*, Role of ^99m^Tc DMSA(V) scintigraphy in postoperative patients with medullary thyroid carcinoma

1112S5C29 Hall A (08.40 -- 08.50 hrs.)

Phykan M, Malhotra G, Asopa R *et al*, Prognostic impact of serial radioiodine and \[^18^F\]- FDG PET Scans in patients of advanced differentiated thyroid carcinoma.

1112S5C30 Hall A (08.50 -- 09.00 hrs.)

Sahoo M K, Singhal A, Dhull V.S. *et al*, Role of 131I SPECT -- CT as a complimentary tool to 131I diagnostic and post therapy whole body scintigraphy in management modification of differentiated thyroid carcinoma.

1112S5C31 Hall A (09.00 -- 09.10 hrs.)

Bhagel NS, Rajashekharrao B, Abhyankar A *et al*, Estimation of late (24 hrs.) radioiodine uptake using early (2 hrs.) uptake measurement in patient of thyrotoxicosis.

1112S5C32 Hall A (09.10 -- 09.20 hrs.)

Shwetal P, Lorenzo B, Catherine P *et al*, Thyroid Isotope Scan; Can it predict transient or permanent hypothyroidism in babies with borderline TSH values on screening test?

1112S5C33 Hall A (09.20 -- 09.30 hrs.)

Gandhi S, Abhyankar A, Basu S *et al*, Dual malignancies in the setting of Thyroid carcinoma: Synchronous or Metachronous Nature and other variables associated with dual malignancies including impact of Radioiodine treatment on occurrence of second malignancy.

1112S5C92 Hall A (09.30 -- 09.40 hrs.)

Muthu G S, Mitra S, Computation of Differential Renal Function of Ectopic Kidneys

1112S5P94 Hall A (09.40 -- 09.50 hrs.)

Chakraborthy D, Bhattacharya A, Mittal B R *et al* Comparison of ^99m^Tc Methylene di phosphanate planar and SPECT / CT Bone Scan and \[^18^F\]Fluoride PET/CT bone scan in detection of skeletal metastasis in patients with carcinoma urinary bladder.

1112S5P95 Hall A (09.50 -- 10.00 hrs.)

Swaroop K, Somashekarappa H M, Jayachandran *et al*, 14C Urea Breath Test as a diagnostic toll in Helicobacter pylori infection studies

**9^th^ December, 2011 (Friday)**

**Convener: Mr. B. S. Jagadish Babu, Chennai**

0912PP34 Studio 1 (14.00 -- 16.00 hrs.)

Chaudhari P, Ghosh S, Nandy S *et al*, Initial Data from a first PET / SPECT- CT small animal imaging system and its application in the preclinical studies

0912PP35 Studio 1 (14.00 -- 16.00 hrs.)

Pandey A K, Partick K, Thulkar S *et al*, Quality control of Kodak Dry view 8900 processor: optical density variation on the image printed on the film of size 8" × 10" and 14" × 17"

0912PP36 Studio 1 (14.00 -- 16.00 hrs.)

Sharma P, Singh H, Kumar R *et al*, Indeterminate lesion on planar bone scintigraphy in lung cancer patients: SPECT, CT or SPECT--CT.

0912PP37 Studio 1 (14.00 -- 16.00 hrs.)

Bhadwal M, Singhal S, Das T *et al*, Preparation and preliminary biological evaluation of 177Lu- labeled porphyrin DOTA conjugate as possible tumour targeting agent.

0912PP38 Studio 1 (14.00 -- 16.00 hrs.)

Singhal S, Bhadwal M, Das T *et al*, Preparation and preliminary biological evaluation of 90Y- labeled porphyrin DOTA conjugate as possible targeted tumour therapy.

0912PP39 Studio 1 (14.00 -- 16.00 hrs.)

Tripathi M, Dhawan V, ShichunPeng *et al*, Comparison of Visual and 'SPM -- supported analysis of FDG- PET images for the differential diagnosis of Parkinsonian Syndromes.

0912PP40 Studio 1 (14.00 -- 16.00 hrs.)

Gupta P, Tripathi M, Jaimini A *et al*, Comparative study between ^99m^Tc- ECD and \[^18^F\] FDG in evaluation of Dementia.

0912PP41 STUDIO 1 (14.00 -- 16.00 hrs.)

Shimpi H H, Shruti H, Menon M D Evaluation ^99m^Tc- microspheres for lung deposition studies using gamma camera

0912PP42 Studio 1 (14.00 -- 16.00 hrs.)

Mukherjee A, Sharma H D, Saxena S *et al*, Bioevaluation of BARC 125I OCU -- PROSTA seeds for prostate cancer treatment.

0912PP43 Studio 1 (14.00 -- 16.00 hrs.)

Sehar R, Tripathi M, D'Souza M *et al*, Comparison of 11C -- Methionone and \[^18^F\] FDG PET imaging for brain tumour -- A perspective pilot study.

0912PP44 Studio 1 (14.00 -- 16.00 hrs.)

Chakraborty S, Chakravarty R, Sharma H D *et al*, Preparation of 68Ga -- Labeled RGD Peptide dimer as a potential PET radiotracer for tumour imaging using a novel 68Ge/68Ga Generator developed in- house.

0912PP45 Studio 1 (14.00 -- 16.00 hrs.)

Meena K V, Hazari P P, Khurana H *et al*, An antisense oligonucleotide conjugated to PET- SPECT contrast agent for *in vivo* imaging of 5HTIA receptor gene expression.

0912PP46 Studio 1 (14.00 -- 16.00 hrs.)

Khurana H, Hazare PP, Meena V K *et al*, Development of ^99m^Tc- labeled EDTA- bis(Glutathione) for imaging GSH efflux in metastatic tumours.

0912PP47 Studio 1 (14.00 -- 16.00 hrs.)

Prakash S, Hazare PP, Singh N *et al*, Design and synthesis of anti- integrin mAb conjugated Bismacrocyclic system for SPECT signal amplification to target β1 and β3 integrins

0912PP48 Studio 1 (14.00 -- 16.00 hrs.)

Chadha N, Tiwari A K, Milton M D *et al*, Computational Study of Novel bis(thiosemicarbazone) analogues: Potential hypoxia imaging agents.

0912PP49 Studio 1 (14.00 -- 16.00 hrs.)

Malhotra G, Potdar P, Choudhary K *et al*, Metabolic patterns of \[^18^F\]FDG uptake in patients of spinal tuberculosis and their comparison with MR findings

0912PP50 Studio 1 (14.00 -- 16.00 hrs.)

Shivanand B, Vasumathi B, Oomen *et al*, Patient specific syringe fractionate unit dose model: Practicable and economic approach of cold kit fractionation in hospital radiopharmacy.

0912PP51 Studio 1 (14:00 to 16:00 hrs.)

Parghane R, Raghav K, Manohar K *et al*, Patterns of Salivary Scintigraphy and correlation with duration of symptoms in Sjogren\'s syndrome.

0912PP52 Studio 1 (14:00 to 16:00 hrs.)

Santosh K, Kaushik A, D'Souza M *et al*, Radiological Safety of Bone Mineral Densitometry Equipment.

0912PP53 Studio 1 (14:00 to 16:00 hrs.)

Kaushik A, Mondal A, Sharma R *et al*, Paediatric Dosimetry of \[^18^F\]FDG Whole Body PET/CT Scans.

0912PP54 Studio 1 (14:00 to 16:00 hrs.)

Ghai A, Mardi S, Kumar P *et al*, Radiopharmacy contamination in nuclear medicine -- A Survey Report.

0912PP55 Studio 1 (14:00 to 16:00 hrs.)

Kumar K R, Rangarajan G K, Vinodkumar M C *et al*. Sentinel lymph node detection by intra operative gamma probe- An update

0912PP56 Studio 1 (14:00 to 16:00 hrs.)

Jain H, Indirani M, Shelley S *et al*, Diagnostic gain of SPECT- CT in skeletal scintigraphy in oncologic and non-oncologic applications.

0912PP57 Studio 1 (14:00 to 16:00 hrs.)

Behera A, Banerjee I, Kakali De *et al*, Synthesis, radiolabelling and biological evaluation of new somatostatin receptor positive tumour imaging agent.

0912PP58 Studio 1 (14:00 to 16:00 hrs.)

Thapa P K, Tripathi M, Jaimini A *et al*, Comparative study between Tc- 99m labelled Methionine and C- 11 Methionine in detection of low grade astrocytoma.

0912PP59 Studio 1 (14:00 to 16:00 hrs.)

Tripathi M, Tripathi M, Jaimini A *et al*, Functional neuroimaging with \[^18^F\] FDG- PET in amnestic Mild congnitive impairment.

0912PP60 Studio 1 (14:00 to 16:00 hrs.)

Soundarajan R, Naswa N, Nazar A H *et al*, Role of \[^18^F\]FDG PET- CT in detection of primary tumors in patients with cervical/extra cervical metastases of unknown origin.

0912PP98 Studio 1 (14:00 to 16:00 hrs.)

Baishya R, Nayak D K, Chatterjee D M Synthesis and Evaluation of ^99m^Tc labeled Nitriimidazoles coupled to small peptides for imaging hypoxia.

0912PP101 Studio 1 (14:00 to 16:00 hrs.)

Nayak D K, Halder K K, Baishya R *et al*, Synthesis and evaluation of Re and ^99m^Tc tricarbonyl complex of Levofloxacin as a novel infection imaging agent.

0912PP102 Studio 1 (14:00 to 16:00 hrs.)

Vimalnath K V, Shetty P, Chirayil V, *et al*, Preparation of 32P by Direct Neutron Activation of Red Phosphorous for the formulation of 32P\[Na3PO4\]

0912PP103 Studio 1 (14:00 to 16:00 hrs.)

Joshi P V, Lele V, Incidence and significance of incidental pituitary uptake on whole body FDG PET/CT scans

0912PP104 Studio1 (14:00 to 16:00 hrs.)

Chirayil V, Ambade R N, Khan M S A *et al*, Validation of dry distillation facility for production of multi Curie 131I in plants.

**10^th^ December, 2011 (Saturday)**

**Convener: Mr. S. Subramanian, Chennai**

1012PP61 Studio 1 (14:00 to 16:00 hrs.)

Goel R, Kashyap R, Manohar K *et al*, Utility of delayed imaging and SPECT/CT in ^99m^Tc labeled red blood cell scintigraphy.

1012PP62 Studio 1 (14:00 to 16:00 hrs.)

Patel R, Tiwari R *et al*, Usefulness of whole body FDG18 PET- CT imaging in comprehensive oncologic management- initial experience.

1012PP63 Studio 1 (14:00 to 16:00 hrs.)

Gokhale S M, Mulay A V *et al*, Estimation of GFR in adult Indian population: A comparison between various prediction equation using S. Creatinine, DTPA scan using Gates protocol and plasma clearance of ^99m^Tc- DTPA.

1012PP64 Studio 1 (14:00 to 16:00 hrs.)

Kumar K K J, Senthil R, Manohar K *et al*, Role of \[^18^F\] FDG- PET/CT in carcinoma penis.

1012PP65 Studio 1 (14:00 to 16:00 hrs.)

Kant K, Sharma P, Singh H *et al*, ^99m^Tc- MDP hybrid SPECT- CT for diagnosis of skull base ostemyelitis: Comparison with planar bone scintigraphy, SPECT and CT.

1012PP66 Studio 1 (14:00 to 16:00 hrs.)

Mathur M, Prasad D C, Asha P *et al*, 131I MIBG imaging in Pheochromocytoma - A case report.

1012PP67 Studio 1 (14:00 to 16:00 hrs.)

Santhosh S, Manohar G, Raghav K *et al*, \[^18^F\] FDG PET- CT in the diagnosis and follow- up of patients with Takayasu arteritis.

1012PP68 Studio 1 (14:00 to 16:00 hrs.)

Gada A, Prasad G, Mahita Y *et al*, Production of 68Ga DOTA- peptide using manual labeling system and 68Ge /68Ga generator -- initial Indian experience of 45 runs.

1012PP69 Studio 1 (14:00 to 16:00 hrs.)

Khangembam C B, Sahoo K M, Singhal A *et al*, Recurrence Detection of Ewing Family of Tumors with \[^18^F\]FDG PET/CT.

1012PP70 Studio 1 (14:00 to 16:00 hrs.)

Khare A, Aggarwal V, Pande S *et al*, Metastases to left calf muscle from carcinoma esophagus -- a rare presentation.

1012PP71 Studio 1 (14:00 to 16:00 hrs.)

Saw S. Tripathi M, D'Souza M *et al*, Predictive Value of FDG PET/CT scan in patients of Lung cancer for detection of extra thoracic metastasis.

1012PP72 Studio 1 (14:00 to 16:00 hrs.)

Ravina M, Jacob M J, Ray S *et al*, Role of high \[^18^F\] FDG uptake values with histopathological factors in primary breast cancer.

1012PP73 Studio 1 (14:00 to 16:00 hrs.)

Shimpi H H, Dand N M, Shidhaye S,S *et al*, radiolabeling and gamma scintigraphy of gastro- retentive nano- particels.

1012PP74 Studio 1 (14:00 to 16:00 hrs.)

Rasmi R R, Shenoy K B, Sarnaik J *et al*, Development of IRMA for sero- diagnosis of human C- peptide.

1012PP75 Studio 1 (14:00 to 16:00 hrs.)

Zankl C, Baumagart D, Hubner S *et al*, High -- yielding fully- automated synthesis of \[^18^F\]fluoromethylcholine using a GE Tracer LabR MXFDG synthesizer.

1012PP76 Studio 1 (14:00 to 16:00 hrs.)

Chauhan K, Kadiyala K G, Adhikari A *et al*, Synthesis and biological evaluation of Thiocarbamate derivatized estradiol as SPECT Agent for ^99m^Tc.

1012PP77 Studio 1 (14:00 to 16:00 hrs.)

Pooja, Anjani K, Tiwari *et al*, Design and synthesis of neuro- catecholamine analogue and their efficiency as radiopharmaceutical.

1012PP78 Studio 1 (14:00 to 16:00 hrs.)

Adhikari A, Chauhan K, Kadiyala K G *et al*, Development of estradiol conjugate with macrocyclic chelate(DOA- Act- Est) as SPECT/PET radiopharmaceutical for tumor imaging.

1012PP79 Studio 1 (14:00 to 16:00 hrs.)

Kadiyala K G, Chauhan K, Adhikari A *et al*, Synthesis and biological evaluation of chalcone derivatives with ^99m^Tc as potential probe for detection of β- amyloid plagues.

1012PP80 Studio 1 (14:00 to 16:00 hrs.)

Aggarwal S, Anjani K. Tiwari *et al*, Design and synthesis of ^99m^Tc- Anthrquinone based analogues for nuclear medicine application.

1012PP81 Studio 1 (14:00 to 16:00 hrs.)

Sarika, Bhattacharya A, Kochhar R *et al*, Radiation exposure during leukocyte labeling process.

1012PP82 Studio 1 (14:00 to 16:00 hrs.)

Pathak C.M, Kaur B, Bhasin D K *et al*, Comparative performance of capsulated vs non- capsulated 14C- urea breath test for the detection of Helicobacter pylori infection.

1012PP83 Studio 1 (14:00 to 16:00 hrs.)

Saini N, Vashney R, Tiwari A.k *et al*, Design and synthesis of DTPA- βamyloid conjugate for SPECT imaging.

1012PP84 Studio 1 (14:00 to 16:00 hrs.)

Ponnappan A, Mathur M, Kumar S *et al*, "Technical issue to improve diuresis renography".

1012PP85 Studio 1 (14:00 to 16:00 hrs.)

Sneha M, Monteiro P, Shetye B *et al*, PET- CT Imaging using half the recommended activity.

1012PP86 Studio 1 (14:00 to 16:00 hrs.)

Gocher K A, Tandon P *et al*, Radiological safety in using 13N radioisotope in the PET facility in India.

1012PP87 Studio 1 (14:00 to 16:00 hrs.)

Kaur A, Sharma S, Mittal B R *et al*, High radiation area survey during the running of the Cyclotron.

1012PP88 Studio 1 (14:00 to 16:00 hrs)

Kumar S Ch, Pandit N, Kumar R *et al*, Importance of isotope scan amongst the imaging modalities.

1012PP89 Studio 1 (14:00 to 16:00 hrs.)

Mahajan S, Tripathi M, Jaimini A *et al*, Comparison of ^99m^Tc- labeled Menthionine and 11C Menthionine radiotracer in the detection of breast carcinomas.

1012PP90 Studio 1 (14:00 to 16:00 hrs.)

Arun S, Abrar L, Sampath S *et al*, Role of \[^18^F\] FDG PET- CT in the evaluation of cases of renal cell carcinoma post nephrectomy.

1012PP91 Studio 1 (14.00 to 16.00 hrs.)

Gupta C, Pankaj P, Verma R *et al*, Role of 68Gallium labeled DOTANAC PET- CT in evaluation of Neuroendocrine tumor.

1012PP97 Studio 1 (14.00 to 16.00 hrs.)

Lakshminarayanan N, Arjun G, Rajan M G R, Preparation of 18^F^ -- Fluoroethyltyrosine (FET): Preliminary studies
